Silver Oak Securities Incorporated Invests $742,000 in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Silver Oak Securities Incorporated acquired a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 8,626 shares of the company’s stock, valued at approximately $742,000.

Other institutional investors have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of VanEck Pharmaceutical ETF by 51.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after purchasing an additional 84,273 shares during the period. Thrivent Financial for Lutherans increased its position in shares of VanEck Pharmaceutical ETF by 33.6% during the third quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after buying an additional 59,025 shares during the period. Miller Investment Management LP raised its stake in VanEck Pharmaceutical ETF by 13.4% during the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after buying an additional 24,446 shares during the last quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its holdings in VanEck Pharmaceutical ETF by 117.4% in the fourth quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock valued at $17,256,000 after buying an additional 108,000 shares during the period. Finally, Adamsbrown Wealth Consultants LLC boosted its position in VanEck Pharmaceutical ETF by 102.3% during the fourth quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock valued at $12,910,000 after acquiring an additional 75,659 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Down 0.4 %

Shares of VanEck Pharmaceutical ETF stock opened at $89.40 on Friday. The company has a market cap of $557.86 million, a P/E ratio of 21.04 and a beta of 0.72. The business has a 50-day moving average price of $87.76 and a two-hundred day moving average price of $91.73. VanEck Pharmaceutical ETF has a 1-year low of $84.48 and a 1-year high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a $0.411 dividend. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.